RayzeBio (RYZB) 30-day option implied volatility near upper end of range

RayzeBio (NASDAQ: RYZB) 30-day option implied volatility is at 91; compared to its 52-week range of 20 to 94 into Bristol Myers (BMY) to acquire RayzeBio for $62.50 per share in cash.

You May Also Be Interested In

• Darden Restaurants (DRI) call put ratio 1.9 calls to 1 put as share price up 2.6% into the expected release of quarter results
• GraniteShares 2x Short SpaceX Daily ETF (SNK) call put ratio 2.6 calls to 1 put
• Cerebras Systems (CBRS) 16998 contracts of August 115 puts trade, share price down 17.5%